VBVarun Bhardwaj

Varun Bhardwaj

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Varun Bhardwaj has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Small hybrid heteroaromatics: resourceful biological tools in cancer research

    by Vikrant Abbot, Poonam Sharma, Saurabh Dhiman, Malleshappa N. Noolvi, Harun M. Patel, Varun Bhardwaj

    Nowadays, hybrid drugs containing two or more covalently linked known potential pharmacophores are designed to simultaneously modulate multiple targets of multifactorial diseases to overcome the side effects associated with a single drug.


  • Top Cited Papers

    Pyrrole: a resourceful small molecule in key medicinal hetero-aromatics

    by Varun Bhardwaj, Divya Gumber, Vikrant Abbot, Saurabh Dhiman, Poonam Sharma

    Pyrrole is widely known as a biologically active scaffold which possesses a diverse nature of activities. The combination of different pharmacophores in a pyrrole ring system has led to the formation of more active compounds. Pyrrole containing analogs are considered as a potential source of biologically active compounds that contains a significant set of advantageous properties and can be found in many natural products. The marketed drugs containing a pyrrole ring system are known to have many biological properties such as antipsychotic, β-adrenergic antagonist, anxiolytic, anticancer (leukemia, lymphoma and myelofibrosis etc.), antibacterial, antifungal, antiprotozoal, antimalarial and many more. Due to the diversity of these analogs in the therapeutic response profile, many researchers have been working to explore this skeleton to its maximum potential against several diseases or disorders. In this review, attempts have been made to disclose various tactical approaches to synthesize pyrrole and pyrrole containing analogs. The structure–activity relationship studies have been discussed along with their therapeutic applications which have been reported during last decade. Some molecules as the main components of the market and clinical trials have also been discussed.


  • Intermolecular interactions of CTAB and potential oxidation inhibitors: physico-chemical controlled approach for food/pharmaceutical function

    by Varun Bhardwaj, Kundan Sharma, S. Chauhan, Poonam Sharma

    We report the impact of lipophilic oxidation inhibitors i.e. butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) on cationic surfactant, cetyltrimethylammonium bromide (CTAB) properties in short chain alcohols and their hydroalcoholic solutions. Considering the extensive employment of BHA and BHT in human products, controlled physicochemical approaches were taken into consideration. Principally, density (ρ), ultrasonic sound velocity (u) and viscosity (η) measurements were carried out at specific temperatures T = (298.15, 303.15 and 308.15) K. The physico-chemical parameters apparent molar volume (Vϕ) and apparent molar adiabatic compression (Kϕ,S) were calculated and revealed the existence of hydrophobic interactions whereas, viscosity measurements depicted the region of micellization. Additionally, 1H NMR spectroscopic study was employed to interpret the intermolecular interaction of antioxidants within the micellar structure. 1H NMR analysis suggested the intermolecular interaction especially in the hydrophilic head and interface region of the surfactant with regard to shifting obtained within spectrum.


  • A novel surfactant aided micellar system of oxidation inhibitors in clotrimazole bioadhesive gel: development, characterization, in vitro and in vivo antifungal evaluation against Candida clinical isolates

    by Varun Bhardwaj, Jitender Monga, Amit Sharma, Shailesh Sharma, Arun Sharma, Poonam Sharma

    Clotrimazole (CLZ) is a widely used antifungal agent with poor aqueous solubility, which requires the development of new delivery systems to improve its therapeutic activity. However, butylatedhydroxy anisole (BHA) and butylatedhydroxy toluene (BHT) have been known as potential antioxidants with antimicrobial properties. In an attempt to develop a better formulation with an antifungal profile, a surfactant aided antioxidant micellar system was dispersed within a clotrimazole gel formulation. Initially, the gel library was prepared and subjected to in vitro evaluation. Based on in vitro release and kinetic profiles, the best three formulations were selected for further analysis. Moreover, in vitro antifungal activity (MIC) and fractional inhibitory concentration index (FICI) against different drug resistant and susceptible Candida isolates were carried out and directed to the best among the 27 formulations. The optimized best selected formulation was thereafter evaluated via morphology studies and in vivo antifungal evaluation. Morphology studies depicted the distribution of micellar structures within the polymeric gel network as well as the contact activity mechanism against Candida albicans. The physicochemical characterization showed that average micellar size was lower than ∼160 nm, low polydispersity index, negative zeta potential and gel pH 6.9. After 60 days, no significant change was observed within the formulation. Photostability studies revealed that antioxidants eminently inhibit the drug degradation under UV radiation with improved drug stability. In addition, in vivo antifungal activity was investigated on experimentally induced cutaneous infection in immunosuppressed Sprague Dawley (SD) rats. The in vivo study confirmed the maximum therapeutic efficacy, as the lowest number of cfu ml−1 was recorded. Conclusively, this study provide a good skin targeting effect and may be promising for stable and effective topical delivery of CLZ offering a maintained localized effect.


  • Quantitative structure–activity relationship (QSAR) studies as strategic approach in drug discovery

    by Harun M. Patel, Malleshappa N. Noolvi, Poonam Sharma, Varun Jaiswal, Sumit Bansal, Sandeep Lohan, Suthar Sharad Kumar, Vikrant Abbot, Saurabh Dhiman, Varun Bhardwaj


  • Drug–surfactant interaction: thermo-acoustic investigation of sodium dodecyl sulfate and antimicrobial drug (levofloxacin) for potential pharmaceutical application

    by Varun Bhardwaj, Tarun Bhardwaj, Kundan Sharma, Abhishek Gupta, S. Chauhan, Swaranjit Singh Cameotra, Shailesh Sharma, Richa Gupta, Poonam Sharma

    In the present study, the advantages of surfactant micelles as drug delivery vehicles are taken into consideration, and the impact of the potential antimicrobial drug (levofloxacin) on the micellar system of anionic surfactant (SDS) has been studied. It would therefore be interesting to evaluate the region of micelle formation in order to design a system that could prove valuable in pharmaceutical formulations. In this context, conductance study, critical micelle concentration (CMC), and standard thermodynamic parameters of micellization, namely, ΔHo m, ΔGo m and ΔSo m, have been evaluated at four different temperatures (298.15 to 313.15) K. Molar volume and compressibility measurements have also been carried out to evaluate the apparent molar volume and apparent molar adiabatic compression of drug–surfactant complex and discussed in terms of the solute–solute and solute–solvent interactions. In addition, spectroscopic analysis (FTIR and 1H-NMR) confirmed the presence of intermolecular interaction between levofloxacin–SDS moiety within the studied concentration. In conclusion, this study provides an indication to assess and develop surfactant immobilized levofloxacin for better biological activity.